Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Abramson Cancer Center at Penn Medicine
Canadian Cancer Trials Group
MacroGenics
National Institutes of Health Clinical Center (CC)
Bayer
Psyence Australia Pty Ltd
Jazz Pharmaceuticals
University of Florida
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Daiichi Sankyo
Acrivon Therapeutics
Sichuan Baili Pharmaceutical Co., Ltd.
Washington University School of Medicine
Dana-Farber Cancer Institute
Faeth Therapeutics
GlaxoSmithKline
Mayo Clinic
Dana-Farber Cancer Institute
Iovance Biotherapeutics, Inc.
Corcept Therapeutics
Jonsson Comprehensive Cancer Center
Yale University
AstraZeneca
Dana-Farber Cancer Institute
Yonsei University
3D Medicines
Yonsei University
Fudan University
Peking University People's Hospital
Fudan University
Yonsei University
Queensland Centre for Gynaecological Cancer
Baylor College of Medicine
Vall d'Hebron Institute of Oncology
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Hansoh BioMedical R&D Company
Peking University People's Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
University Medical Center Groningen